Source: International Congress 2016 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vincent Ninane (Bruxelles, Belgium), Vincent Ninane, Jean-Louis Corhay, Paul Germonpré, Wim Janssens, Guy Joos, Giuseppe Liistro, Walter Vincken, An Lehouck. Inhaled treatment of COPD: A delphi consensus statement. Eur Respir J 2016; 48: Suppl. 60, 306

Member's Comments

No comment yet.

Related content which might interest you: Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD? Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Inhalation technique education and its impact in asthma and COPD Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Educational inhaler technique interventions in asthma & COPD patients: A systematic review Source: International Congress 2016 – Management of asthma and COPD in primary care Year: 2016 Reproducibility of inhaler use and pulmonary drug deposition in COPD Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Real-life effectiveness of budesonide/formoterol for the management of asthma and COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Hospital treatment costs of exacerbations in COPD patients with indications for LTOT Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014